Log in

Moderna’s COVID-19 vaccine 94.5 percent effective in Phase 3 study

By Bethany Blankley | The Center Square
Posted 11/16/20

(The Center Square) – Biotech company Moderna announced Monday that its new COVID-19 vaccine has proven to be 94.5 % effective.

The company said it intends to submit for an Emergency Use …

This item is available in full to subscribers.

Please log in to continue

Log in

X
X